1. From the Division of Molecular Immunology and the Division of Cellular Immunology, MRC National Institute for Medical Research, London NW7 1AA, United Kingdom; the Division of Molecular Genetics, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; and the Cancer Biology and Molecular Haematology Units, Camelia Botnar Laboratories, Institute of Child Health, London WC1N 1EH, United K